Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jun;68(6):1386-97.
doi: 10.1086/320592. Epub 2001 May 8.

The molecular basis of X-linked spondyloepiphyseal dysplasia tarda

A K Gedeon  1 , G E Tiller, M Le Merrer, S Heuertz, L Tranebjaerg, D Chitayat, S Robertson, I A Glass, R Savarirayan, W G Cole, D L Rimoin, B G Kousseff, H Ohashi, B Zabel, A Munnich, J Gecz, J C Mulley
Affiliations

The molecular basis of X-linked spondyloepiphyseal dysplasia tarda

A K Gedeon et al. Am J Hum Genet. 2001 Jun.

Abstract

The X-linked form of spondyloepiphyseal dysplasia tarda (SEDL), a radiologically distinct skeletal dysplasia affecting the vertebrae and epiphyses, is caused by mutations in the SEDL gene. To characterize the molecular basis for SEDL, we have identified the spectrum of SEDL mutations in 30 of 36 unrelated cases of X-linked SEDL ascertained from different ethnic populations. Twenty-one different disease-associated mutations now have been identified throughout the SEDL gene. These include nonsense mutations in exons 4 and 5, missense mutations in exons 4 and 6, small (2-7 bp) and large (>1 kb) deletions, insertions, and putative splicing errors, with one splicing error due to a complex deletion/insertion mutation. Eight different frameshift mutations lead to a premature termination of translation and account for >43% (13/30) of SEDL cases, with half of these (7/13) being due to dinucleotide deletions. Altogether, deletions account for 57% (17/30) of all known SEDL mutations. Four recurrent mutations (IVS3+5G-->A, 157-158delAT, 191-192delTG, and 271-275delCAAGA) account for 43% (13/30) of confirmed SEDL cases. The results of haplotype analyses and the diverse ethnic origins of patients support recurrent mutations. Two patients with large deletions of SEDL exons were found, one with childhood onset of painful complications, the other relatively free of additional symptoms. However, we could not establish a clear genotype/phenotype correlation and therefore conclude that the complete unaltered SEDL-gene product is essential for normal bone growth. Molecular diagnosis can now be offered for presymptomatic testing of this disorder. Appropriate lifestyle decisions and, eventually, perhaps, specific SEDL therapies may ameliorate the prognosis of premature osteoarthritis and the need for hip arthroplasty.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the spectrum of mutations of the SEDL gene. Solid boxes represent the SEDL ORF, hatched boxes represent the UTR of the gene. Twenty-one different mutations of all types were found to have pathogenic consequences in 30 unrelated SEDL cases. Asterisks (*) indicate recurrent mutation events.
Figure 2
Figure 2
RT-PCR analysis of the SEDL gene in patient 27 (insertion/deletion of intron 5) and patient 2 (deletion of exon 3). Total RNA from blood lymphocytes was reverse transcribed with Superscript II reverse transcriptase (see Subjects, Material, and Methods section) and was PCR amplified with SEDL primers. Schematic diagrams indicate the positions of the RT-PCR primers used, the SEDL mutations tested, and the occurrence of the alternative splicing of exon 2. “gDNA” denotes normal genomic DNA used as a control; plus (+) and minus (−) signs denote presence and absence, respectively, of reverse transcriptase during the reverse transcription step of the RT-PCR; the asterisk (*) denotes presence of heteroduplexes; and pUC/HpaII and SPPI/EcoRI are molecular-weight markers. A, Primers spanning SEDL exons 1–4. These primers amplify a 451-bp SEDL-gene product, when exon 2 is spliced in, or a 309-bp product, when exon 2 is spliced out. These two primers also amplify genomic DNA of the chromosome 19 (SEDLP1) pseudogene (309-bp product). This product was present in lymphocyte RNA from patient 27. B, Primers spanning exons 3–6 of SEDL. When these primers were used, no SEDL PCR product was amplified from patient 27's lymphocyte RNA, indicating alternative 3′ processing of the SEDL RNA, as a consequence of the insertion/deletion mutation. Esterase D (ESD) RT-PCR is used as a control of RNA quality. C, RT-PCR amplification using primers spanning exons 1–6 from patient 2's lymphocyte RNA. This patient carries a deletion of exon 3. Exon 3 is missing from its spliced SEDL transcript, demonstrated as a shift of 112 bp (exon 3 size) of both SEDL exon 2+ and exon 2− isoforms.
Figure 3
Figure 3
Sequence chromatograms of two common mutations. Restriction digestion of exon 3 and exon 4 PCR products with TaiI detects half of the recurrent mutations, accounting for >56% of all SEDL cases. A, IVS3+5G→A mutation, which abolishes a TaiI site (underlined) so that the 265-bp exon 3 PCR product is resistant to cleavage into 197-bp and 68-bp fragments. B, 157–158delAT mutation in exon 4, which creates a TaiI site cleaving the 289-bp product into 103-bp and 184-bp fragments. Carriers can be identified. A = affected, C = carriers, and N = normal control.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

Electronic-Database Information

    1. GenBank, http://www.ncbi.nlm.nih.gov/Genbank/index.html (for SEDL mRNA [accession number NM_014563] and SEDL exons 1 [accession number AF157060], 2 [accession number AF157061], 3 [accession number AF157062], 4 [accession number AF157065], 5 [accession number AF157064], and 6 [accession number AF157065])
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for SEDT [MIM 271600, MIM 184100], SEDL[MIM 300202], and SEDL [SEDT, X-linked] [MIM 313400])

References

    1. Ala-Kokko L, Baldwin CT, Moskowitz RW, Prockop DJ (1990) Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci USA 87:6565–6568 - PMC - PubMed
    1. Bannerman RM, Ingall GB, Mohn JF (1971) X-linked spondyloepiphyseal dysplasia tarda: clinical and linkage data. J Med Genet 8:291–301 - PMC - PubMed
    1. Beighton P (1997) Hereditary noninflammatory arthropathies. In: Rimoin DL, Connor JM, Pyeritz RE (eds) Emery and Rimoin’s principles and practice of medical genetics, 3d ed. Vol II. Churchill Livingstone, New York, pp 2773–2777
    1. Bernard LE, Chitayat D, Weksberg R, Van Allen MI, Langlois S (1996) Linkage analysis of two Canadian families segregating for X linked spondyloepiphyseal dysplasia. J Med Genet 33:432–434 - PMC - PubMed
    1. Bieganski T, Dawydzik B, Kozlowski K (1999) Spondylo-epimetaphyseal dysplasia: a new X-linked variant with mental retardation. Eur J Pediatr 158:809–814 - PubMed

Publication types

MeSH terms